Your cart is currently empty!
Tag: Infections
Oregano oil – CANDIDA AWAY PLUS – useful in respiratory infections – 1 Bottle
Oregano oil – CANDIDA AWAY PLUS – useful in respiratory infections – 1 Bottle
Price : 21.95
Ends on : N/A
View on eBay
Oregano oil has long been praised for its powerful antifungal and antibacterial properties, making it a popular natural remedy for a wide range of health conditions. One of the most common uses of oregano oil is in the treatment of candida overgrowth, a condition caused by an overgrowth of yeast in the body.Our CANDIDA AWAY PLUS oregano oil supplement is specially formulated to help combat candida overgrowth and promote a healthy balance of gut flora. This potent supplement is designed to help support your immune system and promote overall wellness.
In addition to its benefits for candida overgrowth, oregano oil is also useful in the treatment of respiratory infections. Its antimicrobial properties make it an effective remedy for conditions such as bronchitis, sinus infections, and the common cold.
Each bottle of our CANDIDA AWAY PLUS oregano oil supplement contains a powerful blend of oregano oil, caprylic acid, and other natural ingredients that work together to support your body’s natural defenses. Give your immune system a boost with our CANDIDA AWAY PLUS oregano oil supplement today!
#Oregano #oil #CANDIDA #respiratory #infections #Bottle,ages 3+PET KING BRANDS Zymox Otic Enzymatic Solution for Dogs and Cats to Soothe Ear Infections Without Hydrocortisone for Itch Relief, 1.25oz
Price: $19.99
(as of Dec 26,2024 01:26:05 UTC – Details)
Do not pre-clean ear prior to or during use. Doing so will disrupt the enzyme system. Do not use in pets with known or suspected ear drum rupture or with known or suspected sensitivity to corticosteroids such as pregnant or lactating females or exotics. Do not allow water in or near ear during use. If condition persists or worsens, consult a veterinarian. Consult a veterinarian before administering in conjunction with other products. Keep out of the reach of children. Not for use in humans.
Is Discontinued By Manufacturer : No
Package Dimensions : 3.9 x 1.93 x 1.22 inches; 1.6 ounces
Item model number : 667334321258
Date First Available : May 25, 2006
Manufacturer : Pet King Brands
ASIN : B000FUOCWMEar care for dogs and cats – soothes ear infections, redness and inflammation for pets of all ages
Gentle, no-sting formula
Solution provides a safe, natural alternative to antibiotics; Hydrocortisone-free for sensitive pets
No pre-cleaning of painful ears required – fill ear canal and let antimicrobial solution get to work
Patented LP3 Enzyme System helps clear ear secretions and promotes healthy earsCustomers say
Customers find the product effective for cleaning and reducing the smell of ears. They say it clears up yeasty, infected, and red ears quickly. Many customers appreciate its ease of application, quality, and lack of scratching. However, some have differing views on whether it provides good value for money.
AI-generated from the text of customer reviews
Are you looking for a solution to soothe your pet’s ear infections without the use of hydrocortisone? Look no further than PET KING BRANDS Zymox Otic Enzymatic Solution for Dogs and Cats! This 1.25oz bottle is specially formulated to provide relief for your furry friend without the need for harsh chemicals.Zymox Otic Enzymatic Solution works by utilizing natural enzymes to help combat ear infections and inflammation. This gentle yet effective formula is safe for both dogs and cats, making it a versatile option for pet owners with multiple furry companions.
Say goodbye to itching and discomfort caused by ear infections, and give your pet the relief they deserve with PET KING BRANDS Zymox Otic Enzymatic Solution. Trust in the power of this trusted brand to provide your pet with the care they need.
#PET #KING #BRANDS #Zymox #Otic #Enzymatic #Solution #Dogs #Cats #Soothe #Ear #Infections #Hydrocortisone #Itch #Relief #1.25oz, IT SolutionsSTI54: A Novel Approach to Treating Resistant Infections
In recent years, the rise of antibiotic-resistant infections has become a major concern in the medical community. Traditional antibiotics are becoming less effective in treating these infections, leading to an urgent need for new and innovative treatment options. One promising approach is the development of STI54, a novel compound that has shown great potential in combating resistant infections.STI54 is a synthetic peptide that was designed to target and disrupt the cell membranes of bacteria, making it difficult for them to survive and replicate. Unlike traditional antibiotics, which target specific bacterial proteins or enzymes, STI54 has a broad spectrum of activity against a wide range of bacteria, including those that are resistant to multiple antibiotics.
One of the key advantages of STI54 is its ability to overcome mechanisms of resistance that bacteria have developed against traditional antibiotics. By targeting the bacterial cell membrane, STI54 is able to bypass many of the common resistance mechanisms that bacteria use to evade the effects of antibiotics. This makes STI54 a valuable tool in the fight against resistant infections.
In preclinical studies, STI54 has shown strong antibacterial activity against a variety of pathogens, including multidrug-resistant strains of bacteria such as MRSA and Pseudomonas aeruginosa. Additionally, STI54 has been shown to be effective in treating biofilm-related infections, which are notoriously difficult to eradicate with traditional antibiotics.
Another benefit of STI54 is its low potential for inducing resistance in bacteria. Because of its unique mechanism of action, bacteria are less likely to develop resistance to STI54 compared to traditional antibiotics. This could help to prolong the effectiveness of STI54 as a treatment option for resistant infections.
Clinical trials are currently underway to evaluate the safety and efficacy of STI54 in humans. Early results have been promising, with STI54 showing good tolerability and the potential to be an effective treatment for a variety of resistant infections. If successful, STI54 could become a valuable addition to the arsenal of antibiotics available to healthcare providers.
In conclusion, STI54 represents a novel and promising approach to treating resistant infections. Its ability to target and disrupt bacterial cell membranes, combined with its low potential for inducing resistance, make it a valuable tool in the fight against antibiotic-resistant bacteria. As research into STI54 continues, it holds the potential to become a critical weapon in the battle against resistant infections.